drugset
Drugs / FOSDEVIRINE
last change Aug 2012 re-read 9 days ago

FOSDEVIRINE

also known as GSK2248761 · Fosdevirina · GSK 2248761A · IDX-899

Small molecule

Developed for
HIV infectious disease
Investigated by
GlaxoSmithKline · ViiV Healthcare

Trials 11

today NCT01283100 · Ph 1 NCT01273103 · Ph 1 NCT01231555 · Ph 2 NCT01199731 · Ph 2 NCT01209117 · Ph 1 NCT01195974 · Ph 1 NCT01138072 · Ph 1 NCT01101893 · Ph 1 NCT01031472 · Ph 1 NCT00945282 · Ph 2 NCT00920088 · Ph 1
2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 18 trials
Phase 1 NCT01283100 Mar 2011 HIV infectious disease ViiV Healthcare Withdrawn No outcome recorded
Phase 1 NCT01273103 Jan → Feb 2011 HIV infectious disease ViiV Healthcare Withdrawn No outcome recorded
Phase 1 NCT01195974 Sep 2010 → Feb 2011 HIV infectious disease ViiV Healthcare Terminated No outcome recorded
Phase 1 NCT01209117 Sep 2010 → Jan 2011 HIV infectious disease, Herpesviridae infectious disease ViiV Healthcare Completed No outcome recorded
Phase 1 NCT01138072 Jun → Aug 2010 HIV infectious disease GlaxoSmithKline Completed No outcome recorded
Phase 1 NCT01101893 Apr → Jun 2010 HIV infectious disease ViiV Healthcare Completed No outcome recorded
Phase 1 NCT01031472 Dec 2009 → Mar 2010 HIV infectious disease ViiV Healthcare Completed No outcome recorded
Phase 1 NCT00920088 Jun → Nov 2009 HIV infectious disease GlaxoSmithKline Completed No outcome recorded
Phase 23 trials
Phase 2 NCT01231555 Nov 2010 → Jul 2011 HIV infectious disease ViiV Healthcare Terminated No outcome recorded
Phase 2 NCT01199731 Oct 2010 → Jul 2011 HIV infectious disease ViiV Healthcare Terminated No outcome recorded
Phase 2 NCT00945282 Oct → Nov 2009 HIV infectious disease ViiV Healthcare Completed Mixed

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 13 sources stand behind the page.

FieldValueCited text
Known as FOSDEVIRINE ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗
Known as Fosdevirina ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗
Known as GSK 2248761A ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗
Known as GSK2248761 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01101893 ↗
10

NCT00945282 ↗

NCT01273103 ↗

NCT00920088 ↗

NCT01138072 ↗

NCT01209117 ↗

NCT01031472 ↗

NCT01231555 ↗

NCT01199731 ↗

NCT01195974 ↗

NCT01283100 ↗
Known as IDX-899 ChEMBL registry synonym — accepted as the source's own label CHEMBL2104968 ↗
Action Inhibit “next generation non-nucleoside reverse transcriptase inhibitor GSK2248761” PMID 22288567 ↗ Aug 2012
Modality Small molecule “next generation non-nucleoside reverse transcriptase inhibitor GSK2248761” PMID 22288567 ↗ Aug 2012
Route Oral “Once Daily Oral Dose of GSK2248761” NCT01199731 ↗